Author: Dr. David Lowemann

Novo’s New Obesity Drug Could Be Most Effective Yet

Novo Nordisk is not resting on its laurels. Its blockbuster weight loss drug semaglutide (sold under the brand names Ozempic and Wegovy) is expected to become the world’s top-selling drug franchise next year and may reach a $130 billion market in the next five years,… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, […]

Published on November 4, 2024

Exposure to particular sources of air pollution is harmful to children’s learning and memory

A new study involving 8,500 children from across the United States has revealed that a form of air pollution, largely the product of agricultural emissions, is linked to poor learning and memory performance in 9- and 10-year-olds. The specific pollutant, ammonium nitrate, is also implicated in Alzheimer’s and dementia risk in adults, suggesting that PM2.5 […]

Published on November 4, 2024

Exercise Does Not Reduce Sitting’s Harm to Heart

There’s just something about sitting. New research shows that too much time on sofas and chairs harms the heart – even among people who get the minimum recommended amount of daily exercise. “Taking a quick walk after work may not be enough” to offset the health dangers of… Read Full Article (External Site) Dr. David […]

Published on November 4, 2024